• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.14% Nasdaq Down0.35%

    Keryx Biopharmaceuticals Inc. (KERX)

    -NasdaqCM
    5.06 Down 0.97(16.09%) 4:00PM EDT
    |After Hours : 5.10 Up 0.04 (0.79%) 6:47PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 10,825   7,000   -  
    Cost of Revenue495   -   -  
    Gross Profit 10,330   7,000   -  
    Operating Expenses
    Research Development51,502  34,734  20,031  
    Selling General and Administrative70,057  19,349  7,048  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (111,229) (47,083) (27,079)
    Income from Continuing Operations
    Total Other Income/Expenses Net411  351  4,358  
    Earnings Before Interest And Taxes(110,818)(46,732)(25,360)
    Interest Expense -   -   -  
    Income Before Tax(110,818)(46,732)(25,360)
    Income Tax Expense700   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(111,518)(46,732)(22,721)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (111,518) (46,732) (22,721)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (111,518) (46,732) (22,721)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.